$0.149900
0.00020.13%
At close: Sep 19, 7:58 PM EDT
$0.150100
0.00020.13%
After Hours: 7:58 PM EDT
15 minutes delayed
Comments
Loading...
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock, Earnings Estimates, EPS, And Revenue
Tonix Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 7
EPS Estimate
$-3.110
Quarterly Revenue Estimate
$3.6M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$12.5M
Analyze the earnings history of Tonix Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Tonix Pharmaceuticals (TNXP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-16 | $-19.28 | $-7.20 | -167.8 % |
| Mar 2024 | 2024-05-13 | $-5.76 | $-12.48 | 53.8 % |
| Mar 2024 | 2024-04-01 | $-27.52 | $-52.48 | 47.6 % |
| Sep 2023 | 2023-11-09 | $-58.56 | $-47.68 | -22.8 % |
Tonix Pharmaceuticals (TNXP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-16 | $2.21M | $3.35M | -34.1 % |
| Mar 2024 | 2024-05-13 | $2.48M | $3.80M | -34.7 % |
| Mar 2024 | 2024-04-01 | $3.78M | $3.83M | -1.33 % |
| Sep 2023 | 2023-11-09 | $3.99M | $5.80M | -31.2 % |
FAQ
When is Tonix Pharmaceuticals (NASDAQ:TNXP) reporting earnings?
Tonix Pharmaceuticals (TNXP) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 16, 2024 for Q2.
What were the latest earnings per share (EPS) for Tonix Pharmaceuticals (NASDAQ:TNXP)?
The Actual EPS was $-19.28, which missed the estimate of $-7.20.
What were Tonix Pharmaceuticals’s (NASDAQ:TNXP) revenues?
The Actual Revenue was $2.2M, which missed the estimate of $3.4M.
Browse earnings estimates, EPS, and revenue on all stocks.